Charter Communications (NASDAQ:CHTR) reported third-quarter financial results on Friday. The transcript from the company’s third-quarter earnings call...
Keybanc analyst Ashley Owens maintains FIGS (NYSE:FIGS) with a Overweight and raises the price target from $20 to $27.
– Reuters cites Interfax
Piper Sandler analyst Jason Bednar maintains Becton Dickinson (NYSE:BDX) with a Neutral and raises the price target from $175 to $200.
Style Box ETF report for PWB
Style Box ETF report for JPSE
Style Box ETF report for DHS
The stock continues to slide despite posting strong Q3 earnings.
Nebius reported 454.04% revenue growth versus CoreWeaveâs 112%. NBIS stock remains a Buy while CRWV stock moves to Hold. Click to read my full compa...
Clark Howard spent years watching couples bleed money one warehouse trip at a time, and the fix he landed on sounds almost too simple to work. With Co...
https://www.sec.gov/Archives/edgar/data/1916331/000118518526005219/ncif1110426.htm
Foodservice tie-ups with major chains could make energy drinks a standard meal pairing, a channel that may matter more as overseas sales weigh on marg...
US stock futures were mixed on Friday, November 6, as investors assessed the consequences of a sharp technology-led market sell-off following the Demo...
Keybanc analyst Jackson Ader reiterates Cloudflare (NYSE:NET) with a Overweight and maintains $375 price target.
Price targets for Keurig Dr Pepper have shifted toward the low to low mid US$40 range, with recent moves into the US$38 to US$41 band from firms such ...
The order covers multiple unmanned aerial systems, with associated ground control stations and accessories, and includes a first-year software update ...
T-Mobile US (TMUS) has put product development in the spotlight, rolling out its customizable T-Mix wireless plans alongside a new 5 Gig fiber offer t...
DXP Enterprises (DXPE) just posted third quarter 2026 earnings, reporting sales of US$587.2 million and diluted EPS of US$1.64. Revenue was roughly in...
GSK plc has delivered strong multi year gains for shareholders, and the latest news around its cancer and specialty medicines raises a straightforward...
Loading...